Warning signs include decreased urine output despite increased frequency attempts, dark urine, dizziness, rapid heartbeat, or confusion
In DXA body-composition analyses from the STEP 1 semaglutide program and the SURMOUNT-1 tirzepatide trial, lean mass decreased alongside fat mass, and the STEP 1 extension showed that many participants regained about two-thirds of their lost weight after stopping semaglutide, which is one more reason to protect muscle and training habits while the medication is working
Most studies report nausea rates of 40-45% at some point during treatment, though the severity is typically mild to moderate and tends to diminish over time as the body adjusts
If you buy something through a link in this article, we may earn commission.
And I've had a lot of patients do well, but it's so little